New Additions to Drugs.com for 2025
The following 5 drugs were added to the Drugs.com database in 2025.
Arynta
Jun 24, 2025 - Arynta is an oral solution containing lisdexamfetamine used to treat Attention Deficit Hyperactivity Disorder (ADHD) in adults and children 6 years of age and older and Binge Eating Disorder (BED) in adults.
Harliku
Jun 24, 2025 - Harliku is a hydroxyphenyl-pyruvate dioxygenase inhibitor used to reduce levels of homogentisic acid in the urine of adults with alkaptonuria (AKU), a very rare genetic metabolic disorder.
Ibtrozi
Jun 11, 2025 - Ibtrozi is a kinase inhibitor used to treat locally advanced or metastatic ROS1-positive non-small cell lung cancer (NSCLC) in adults.
Miudella
Apr 2, 2025 - Miudella is a hormone-free, low-dose, copper-releasing intrauterine system (IUS) designed for pregnancy prevention for up to 3 years.
Opdivo Qvantig
Jan 1, 2025 - Opdivo Qvantig is a new formulation of Opdivo that contains hyaluronidase that allows it to be given subcutaneously (under the skin) and over 3 to 5 minutes. Opdivo Qvantig is used to treat adults with certain types of melanoma, non-small cell lung cancer, renal cell carcinoma, squamous cell carcinoma of the head and neck, urothelial carcinoma, colorectal cancer, hepatocellular carcinoma, gastric cancer, or gastroesophageal junction cancer.